The RNA-binding protein TTP is a global post-transcriptional regulator of feedback control in inflammation. by Tiedje, Christopher et al.
7418–7440 Nucleic Acids Research, 2016, Vol. 44, No. 15 Published online 24 May 2016
doi: 10.1093/nar/gkw474
The RNA-binding protein TTP is a global
post-transcriptional regulator of feedback control in
inflammation
Christopher Tiedje1,*,†, Manuel D. Diaz-Mun˜oz2,*,†, Philipp Trulley1, Helena Ahlfors2,
Kathrin Laaß1, Perry J. Blackshear3, Martin Turner2 and Matthias Gaestel1
1Institute of Physiological Chemistry, Medical School Hannover (MHH), 30625 Hannover, Germany, 2Lymphocyte
Signalling and Development, The Babraham Institute, Cambridge CB22 3AT, UK and 3Laboratory of Signal
Transduction, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA; and
Departments of Medicine and Biochemistry, Duke University Medical Center, Durham, NC 27710, USA
Received January 29, 2016; Revised May 13, 2016; Accepted May 16, 2016
ABSTRACT
RNA-binding proteins (RBPs) facilitate post-
transcriptional control of eukaryotic gene ex-
pression at multiple levels. The RBP tristetraprolin
(TTP/Zfp36) is a signal-induced phosphorylated
anti-inflammatory protein guiding unstable mRNAs
of pro-inflammatory proteins for degradation and
preventing translation. Using iCLIP, we have iden-
tified numerous mRNA targets bound by wild-type
TTP and by a non-MK2-phosphorylatable TTP mutant
(TTP-AA) in 1 h LPS-stimulated macrophages and
correlated their interaction with TTP to changes
at the level of mRNA abundance and translation
in a transcriptome-wide manner. The close simi-
larity of the transcriptomes of TTP-deficient and
TTP-expressing macrophages upon short LPS stim-
ulation suggested an effective inactivation of TTP
by MK2, whereas retained RNA-binding capacity
of TTP-AA to 3′UTRs caused profound changes in
the transcriptome and translatome, altered NF-B-
activation and induced cell death. Increased TTP
binding to the 3′UTR of feedback inhibitor mRNAs,
such as Ier3, Dusp1 or Tnfaip3, in the absence of
MK2-dependent TTP neutralization resulted in a
strong reduction of their protein synthesis con-
tributing to the deregulation of the NF-B-signaling
pathway. Taken together, our study uncovers a
role of TTP as a suppressor of feedback inhibitors
of inflammation and highlights the importance of
fine-tuned TTP activity-regulation by MK2 in order to
control the pro-inflammatory response.
INTRODUCTION
RNA-binding proteins (RBPs) constitute an important
group of post-transcriptional regulators in diverse cellu-
lar processes acting on both coding and non-coding RNAs
(1,2). A prominent role for the post-transcriptional con-
trol by RBPs is emerging especially in the regulation of in-
nate immunity (3). In this context the RBP tristetraprolin
(TTP), encoded by the Zfp36 gene of the Tis11-family, acts
on pro-inflammatory cytokine mRNAs. It guides them for
degradation and/or prevents their efficient translation (4).
This function depends on the RNA helicase Ddx6 (5) or
the 4EHP-GYF complex (6). Distinct sequences such as
AU-rich elements (AREs) in the 3′UTRs of mRNAs reg-
ulate their stability by serving as binding platforms for TTP
(7). During inflammatory conditions triggered by TLR4-
mediated activation of macrophages with lipopolysaccha-
ride (LPS), these mRNAs are stabilized and their transla-
tion is preferentially enhanced (8). The molecular switch
for this regulation relies on the phosphorylation of TTP
by p38MAPK-activated protein kinase 2 (MAPKAPK2 or
MK2) at two conserved serine residues (S52 and S178 in
mouse, S60 and S186 in human) (9). This phosphorylation
results in a sequestration of TTP by 14-3-3 proteins prevent-
ing its mRNA degrading activity (10) and might change
TTP’s RNA affinity to AREs (8). A phosphorylation-
sensitive interaction of TTP with components of the Ccr4-
Not1-deadenylation complex (11–13) and enhanced re-
placement of phospho-TTP by translation-promoting fac-
tors (8) was additionally shown. To better understand the
global regulatory potential of TTP and the consequences of
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phosphorylation-dependent binding to its mRNA targets,
we have applied a combined high-throughput sequencing
approach.
TTP belongs to a group of negative feedback inhibitors
that is crucial for the shutdown of the pro-inflammatory re-
sponse, thereby preventing chronic inflammation (14). The
essential role of these feedback inhibitors, such as TTP,
dual specificity phosphatase 1 (Dusp1), immediate early re-
sponse 3 (Ier3) and tumor necrosis factor alpha-induced
protein 3 (Tnfaip3/A20), has been demonstrated by genetic
deletions, which led to deregulated inflammatory responses
and macrophage death (14–21). Similar to cytokines and
chemokines, the expression of these feedback inhibitors is
increased in macrophages in response to LPS due to the
existence of AREs within their own 3′UTRs (14). Interest-
ingly, the transcription of these feedback inhibitors often
depends on NF-B activity that itself is regarded as part of
an auto-regulatory feedback loop (22,23). In turn, TTP also
blocks nuclear import of NF-B (p65) due to a direct phys-
ical interaction between the proteins and/or due to acting
as a co-repressor on NF-B (24,25).
TTP-deficient mice develop a complex inflammatory
phenotype in part due to the overproduction of tumor
necrosis factor (TNF) (20). By contrast, analysis of the
Zfp36aa/aa transgenic mouse, in which the endogenous TTP
gene was replaced by a non-MK2-phosphorylatable mu-
tant TTP-S52, 178A (TTP-AA), showed attenuated sys-
temic inflammatory response to LPS due to a decrease
in cytokine production (26). Although in this in vivo ap-
proach the mutant TTP-AA is expressed to a much lower
level than wild-type TTP, results indicate that TTP is a
key regulator of inflammation. However, the global molec-
ular pathways controlled by TTP are only partly under-
stood due to the lack of comprehensive knowledge about
TTP-bound mRNA targets. Previous studies, which com-
bined RNA-immunoprecipitation with microarray analy-
sis to identify TTP mRNA targets in mouse embryonic fi-
broblasts (MEFs) (27), macrophages (28), dendritic cells
(29) or primary macrophages (30), have listed and validated
TTP-dependent regulation of mRNA levels and transla-
tion for some TTP mRNA targets, but none of these
studies provided information about direct physical TTP-
nucleic acid interactions. Importantly, not all of the TTP
targets identified contained AREs raising questions about
the specificity of binding (27,29). Recently, photoactivat-
able ribonucleoside-enhanced-crosslinking immunoprecipi-
tation (PAR-CLIP) was used to characterize TTP-RNA in-
teractions on a transcriptome-wide scale in HEK293 cells
(31). However, in this study the forced ectopic expression
of TTP does probably not reflect the TTP-mediated post-
transcriptional mRNA regulation in its physiological con-
text, such as in LPS-stimulated macrophages (31–33).
Here, we report a genome-wide screen to determine
the TTP-RNA interactome in bone marrow derived
macrophages (BMDMs) using individual nucleotide reso-
lution crosslinking and immunoprecipitation (iCLIP) (34)
and high-throughput sequencing-based transcriptomic ap-
proaches. We have generated a protein expression rescue
system in TTP-deficient macrophages that mimics endoge-
nous protein expression of TTP after LPS stimulation.
The system allowed us to address the effects of post-
translational regulation of TTP by MK2 using an inte-
grated systems biology approach by correlating changes
of TTP binding to its mRNA targets with changes in
mRNA abundance and translation during the early stages
of macrophage activation. Our study has identified thou-
sands of novel TTP targets, including mRNAs of cytokines
and chemokines like Gdf15 and Cxcl10, and has also elu-
cidated the global phosphorylation-dependent properties
of TTP. Furthermore, our approach has uncovered the
novel function of TTP as a suppressor of feedback in-
hibitors, such as Dusp1, Ier3 and Tnfaip3 that control the
pro-inflammatory response triggered by LPS. Our obser-
vations underline the importance of MK2-dependent post-
translational TTP regulation for correct NF-B-signaling
and cell survival.
MATERIALS AND METHODS
Cell culture
Generally, macrophages were grown in DMEM contain-
ing 2 mM L-glutamine, 10% (v/v) FCS, 100 U penicillin
G/ml, 100 mg/ml streptomycin and non-essential amino
acids (all purchased from Life Technologies) in a humidi-
fied atmosphere at 37◦C. To obtain bone marrow-derived
macrophages, femurs of 6 week-old mice were flushed and
plated on one 10 cm plate. 10 ng/mlM-CSF (Wyeth/Pfizer)
was added to the medium. The next day non-adherent cells
were transferred to a new 10 cm plate and new medium
containing 10 ng/ml M-CSF was added to the initial plate.
Medium was renewed on both plates after another 3 and
6 days. Cells were scraped and seeded for experiments on
day 9 to 10 after initial plating. Primary TTP-deficient (20)
macrophages were immortalized, stained for macrophage-
specific surface markers and subsequently sorted by FACS
as described previously (35). Immortalized bone mar-
row derived macrophages (BMDMs) were transduced with
retroviruses containing an all-in-one tet-inducible vector
(36) coding for GFP–TTP, GFP–TTP-AA or GFP-only
constructs (for cloning primers see Supplementary Table
S4). Of note, only protein coding sequences for TTP were
inserted in this constructs to avoid autoregulation of TTP
through binding to its own mRNA 3′UTR (37). Plasmids
coding for TTP and TTP-AA described before (8) served
as templates for amplification. Transductions were carried
out as described before (35). Doxycycline and LPS (Sigma,
E. coli O127:B8) were used at 1 g/ml for cell stimulation.
The TTP-deficient MEF cell line was described before (27).
HEK293T,HeLa andRAW264.7 cells weremaintained and
transfected as previously described (38).
Animals
Wild-type (C57BL/6) and Zfp36tm1Pjb (TTP−/−) mice (20)
were bred from heterozygotes and experiments were con-
ducted according to German and international guidelines
and were approved by the ethics committee of Hannover
Medical School (MHH). Genotyping of mice was done us-
ing the wild-type specific primers TTPd and TTPrc1 and
knockout-specific primers TTPd and Tneorc (for primer se-
quences see Supplementary Table S4).
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Flow-cytometry
Cells were scraped in medium and briefly vortexed be-
fore the analysis. An Accuri (Becton Dickinson) system
was used to check the immortalized cells for macrophage-
specific F4/80-PE (eBiosciences, clone BM8) and CD11b-
PE (eBiosciences, clone M1/70) surface marker expression.
To control successful transduction, immortalized cells were
analyzed for GFP-expression upon doxycycline-treatment.
Sorting of GFP-positive cells upon 6 h of doxycycline-
treatment was carried out by the FACS Sorter Core Facility
at the Hannover Medical School.
To measure apoptotic cells, 10 g/ml 7-amino actino-
mycin D (7-AAD, Life Technologies) (39) was added to 0.2-
0.5 × 106 cells collected in 100 l FACS-buffer (1 × PBS,
2 mM EDTA) and incubated for 15 min at 4◦C before de-
termining the percentages of 7-AAD+ cells. Here, after gat-
ing on viable cells in the SSC-A/FSC-A scatter-plot, GFP+
cells were gated and checked for the percentage of 7-AAD+
GFP+ cells. The mean and the corresponding standard de-
viations of three independent experiments are shown.
Fluorescence microscopy
Cells were grown on poly-L-lysine coated (50 g/ml) cov-
erslips for 24 h. After stimulation with doxycycline for 6
h, cells were treated with LPS for the indicated times and
immediately fixed with 4% paraformaldehyde (PFA, in 1×
PBS) for 15 min at room temperature. After blocking with
5% BSA in 1× PBS containing 0.3% Triton X-100, staining
was done with a 1:400 dilution of the anti-p65 (NF-B) an-
tibody (D14E12) XP (Cell Signaling Technology) for 2 h at
room temperature. An anti-rabbit secondary antibody cou-
pled to Alexa Fluor-555 (Molecular Probes, 1:400 dilution
in 1×PBS containing 0.3%TritonX-100) was used to detect
the anti-p65 antibody (2 h at room temperature) together
with Alexa-Fluor 647 Phalloidin (Molecular Probes, 1:400
dilution) to stain for F-actin before nuclear staining with a
DAPI-solution (500 ng/ml) for 10min at room temperature.
Images were taken on a confocal Leica TCS SP2microscope
at the central imaging facility of Hannover Medical School
(MHH).
Quantitative image analysis of NF-B nuclear import
upon LPS stimulation was done using the ImageJ soft-
ware (http://rsb.info.nih.gov/ij/index.html) with the help of
the plug-in JACoP. Mander’s coefficients were determined
for cytosolic (F-actin co-staining) and nuclear (DAPI co-
staining) NF-B localization in the cells. For each genotype
and time point, five independent multi-channel images were
taken and analyzed in a blind approach.
Water soluble tetrazolium (WST-1) proliferation assay
The phosphate-buffered saline solution (Roche # 11 644
807 001) was added directly to the cultured cells and in-
cubated for a minimum of 30 min at 37◦C. 10 l of the
solution were used for 100 l cell culture medium. Cells
were seeded in triplicates in a 96-well format at a density
of 1 × 104 cells/well. Measurements at 450 and 630 nm for
background subtractionwere carried on amultiplate-reader
(Wallac).
SDS-PAGE, western blot and antibodies
SDS-PAGE and western blotting was carried out as de-
scribed before (40). Western Blots were developed using the
ECL-based LAS-3000 (FujiFilm) and the Odyssey scan-
ner (Li-COR Biosciences) system, respectively. The anti-
GAPDH was purchased from Millipore and the anti-
Tubulin from Sigma. Anti-GFP, anti--Actin, anti-pro-
TNF, anti-Tnfaip3, anti-Dusp1 and anti-Ier3 were all
from Santa Cruz Biotechnology whereas all other an-
tibodies were obtained from Cell Signaling. The anti-
TTP (SAK21B) and anti-pTTPS178 antibodies were de-
scribed before (41,42) and kindly provided. HRP-coupled
secondary antibodies were obtained from Dianova and
IRDye-680/800-coupled secondary antibodies were from
Li-COR Biosciences.
For quantification of western blot signals a minimum of
two different exposures was normalized to at least three dif-
ferent exposures of the loading control blot that was de-
rived from the same membrane. All background-reduced
band intensities were determined using the Multi Gauge
V3.2 software (FujiFilm).
Generation of rat-derived TTP-specific (NE2/1.1) and anti-
pan-Tis11 antibodies
Rats were immunized with the N-terminal 84 amino acids
of TTP starting with SLQSMS and fused to GST. The re-
sulting antibody (NE2/1.1, IgG1) was used in a 1:1000 di-
lution for the detection of TTP in western blot. To generate
the anti-pan-Tis11 antibody, rats were immunized with the
C-terminal 164 amino acids of Zfp36l1 (or Tis11b) fused to
GST. The resulting IgG2a was used 1:1000 in western blot
and detected TTP, Zfp36l1 and Zfp36l2.
ELISA
For the detection of mouse Cxcl10 chemokine the DuoSet
kit #DY466-05 (R+D Systems) was used according to the
manufacturer’s instructions. 1 × 104 cells were seeded in
triplicates in a 96-well plate. After attachment to the bot-
tom of the wells, cells were stimulated as indicated.
Luciferase reporter assay measurement
3′UTR Firefly reporter plasmids (see Supplementary Table
S4 for cloning primers) were co-transfected into HeLa cells
together with a Renilla-coding plasmid and TTP or TTP-
AA cloned into pEGFP-C1 (described in (43)) following
previous descriptions (38).
RNA-Isolation, cDNA synthesis and qRT-PCR
RNAwas isolated using either theNucleoSpinRNAextrac-
tion kit (Macherey+Nagel) or TRIzol (Life Technologies)
according to the manufacturer’s instructions. cDNA from
250 to 500 ng RNA was synthesized using the first strand
cDNA synthesis kit (Fermentas/Thermo) in combination
with random hexamer primers. qRT-PCRs were run on a
Rotor-Gene-Q (Qiagen) device using either 2× Probe or 2×
SYBR-Green SensiFast mixes (no ROX, Bioline) according
to the instructions. Primers used in this study are listed in
Supplementary Table S4.
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RNA-stability measurements
10g/mlActinomycinD (Sigma) were added after stimula-
tion of cells to stop the de novo transcription by RNA Poly-
merase II. Samples for RNA-isolation were taken every 15
min after the initial addition of ActinomycinD. RNAs were
further processed as described before (40).
RNA-immunoprecipitation (RNA-IP)
1×106 cells for each individual IP were seeded in 6 cm plates
one day before stimulation with 1 g/ml Doxycycline (6 h)
andLPS (1 h). anti-GFP IPswere performed in the presence
of 0.5 mg/ml heparin (Carl Roth), Phosphatase Inhibitor
Cocktail III (Sigma) and protease inhibitors (Roche) ac-
cording to the instructions described before (44) and mon-
itored by GFP western blot (Supplementary Figure S4a).
Precipitated RNAs were eluted using TRIzol and equal
volumes of eluted RNA were purified and converted into
cDNA. Relative levels of precipitated RNA in relation to
the control GFP-IP were determined by qPCR using the
primers listed in Supplementary Table S4.
Polysome profiling
Polysome profiling of individual mRNAs was described be-
fore (8), with the exception that total lysates were used.
Macrophages were rinsed in ice cold 1× PBS containing
0.1 mg/ml cycloheximide prior to lysis. Total lysates from
10 × 106 cells were separated on a linear 10–50% sucrose
gradient by ultracentrifugation for 2 h at 35 000 rpm using
a SW40.1 Ti rotor (Beckman-Coulter). After centrifugation
12 fractions (1 ml each) per gradient were collected using a
UA-6 UV/VIS (Teledyne/ISCO Inc.) device. The RNA of
each fraction was precipitated overnight with isopropanol
and 3 MNa-acetate at –20◦C and purified using the Nucle-
oSpin RNA kit (Macherey+Nagel) by dissolving the result-
ing pellet in buffer RA1 from the kit. Purified RNAs were
subjected to cDNA synthesis and qRT-PCR as described
above.
Ribosome profiling (RiboSeq) and total RNA sequencing
(RNASeq)
Genome-wide assessment of ribosome-occupancy was as-
sessed using ARTSeq Ribosome profiling kit (Epicentre).
Briefly, 10× 106 macrophages were seeded on a 15 cm plate
the day before induction of TTP expression with doxycy-
clin (6 h treatment) and stimulation with LPS for 1 h. Cells
were rinsed twice with ice cold 1×PBS containing cyclohex-
imide (0.1 mg/ml) before cell extract preparation (≈1 ml).
One tenth (100 l) of the sample was used for total RNA
isolation and library preparation using the Ribo-Zero Gold
Kit (Epicentre) and following instructions in the ARTSeq
Ribosome profiling kit. 200 l of the samples were used
for nuclease digestion and ribosome-protected RNA purifi-
cation prior to cDNA library preparation. cDNA library
size was assessed using High Sensitivity DNAAnalysis Bio-
Analyzer kits (Agilent) and libraries were quantified using
KAPA Library Quantification Kits (Kapa Biosystems). 50
bp SE multiplexed sequencing was done on an Illumina
HiSeq2500 device.
Individual-nucleotide resolution crosslinking and immunopre-
cipitation (iCLIP)
iCLIP experiments were performed as previously described
(34). For each experiment 10 × 106 cells were seeded a day
before treatment with doxycycline (1 g/ml) for 6 h accom-
panied by 1 hour stimulation with LPS (1 g/ml). After
washing with ice-cold PBS, intact cells were irradiated with
UV-C light (300 mJ/cm2, Stratalinker 2400) and total cell
extracts were obtained using lysis buffer (50 mM Tris/HCl
[pH 8.0], 150 mM NaCl, 0.5% (v/v) Triton X-100 and 1
mMEDTA) and sonication (3 times for 20 s in ice). Extract
were cleared by centrifugation (15 min at 4◦C) and treated
withRNaseA (0.9375× 10−3 Units/ml, Roche) andDNase
I (20 Units/ml, Ambion) for 3 min at 37◦C and cooled
on ice for 5 min after adding urea to 0.5 M and RNase
inhibitors (266.8 Units of RiboLock, Thermo/Fermentas;
and 133.4 U of RNaseOUT, Life Technologies). Immuno-
precipitation ofGFP–TTP-RNA complexes was performed
using 25 l of Epoxy Dynabeads (M-270, Life Technolo-
gies) coupled GFP-nanobody slurry per 1 ml of total cell
extracts for 1 h at 4◦C. Coupling was described before (45).
Samples were washed with lysis buffer plus 0.5 M Urea (1
x) and low salt-urea wash buffer (50 mM Tris/HCl [pH
8.0], 150 mM NaCl, 0.1% (v/v) Triton X-100 and 0.5 M
Urea) (3x). Samples were vortexed and kept in rotation for
5 min between washes. Next, samples were further washed
using high salt-urea wash buffer (50 mM Tris/HCl [pH
8.0], 1000 mM NaCl, 0.1% (v/v) Triton X-100 and 4 M
Urea) (2×) and PNK wash buffer (20 mM Tris–HCl [pH
7.4], 10 mM MgCl2, 0.2% Tween-20) (3×). Samples were
changed to a new tube before RNA dephosphorylation
by suspending the slurry in RNA dephosphorylation mix
(0.5 l PNK [NEB], 1 l RNase Inhibitor, 2 l 10× PNK
pH 6.5 buffer [NEB] and 17.5 l water). One tenth of the
sample was labeled with 32P-ATP using PNK, whereas an
RNA Linker was ligated to 3′ end of the RNA molecules
present in the rest of the sample. Then, GFP–TTP-RNA
complexes were resolved by electrophoresis (SDS-PAGE)
and transferred to nitrocellulose membranes. Visualization
by autoradiography of radioactively labeled RNA was per-
formed prior to isolation of GFP–TTP-RNA complexes
larger than 75 kDa by incubating the nitrocellulose frag-
ment at 37◦C for 10min with proteinase K (0.14mg, Roche)
in 200 l of PK buffer (100 mM Tris/HCl [pH 7.5], 50 mM
NaCl and 10 mM EDTA). Additional 200 l of PK buffer
plus 7 M urea was added and samples were further incu-
bated at 37◦C for 20 min. RNA isolation was performed
by phenol/chlorophorm extraction and ethanol precipi-
tation, prior retro-transcription of the RNA into cDNA
by using SuperScript III reverse transcriptase and RCLIP
primers with a seven bases barcode (3 know + 4 unknown).
cDNA was gel-purified (6% TBE-urea gels), circularized
using Circligase II and amplified by PCR using Solexa
P5/P7 primers. cDNA libraries from independent experi-
ments were prepared and sequenced using aHTSeq2500 (50
bp SE sequencing).
Bioinformatics
iCLIP data analysis was performed as previously described
(34). Briefly, sample demultiplexing was performed by iden-
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tification of the three known bases of the seven bases
barcode introduced in the 5′ end of the read by the
RCLIP primer. The remaining four unknown bases were
used for identification of unique cDNA counts after re-
moval of PCR duplicate reads. Reads were trimmed to
remove any adaptor sequence and barcodes before map-
ping unique reads to genome mm10 (ensembl75 annota-
tion) using Bowtie. Position -1 was extracted and anno-
tated as the TTP crosslink site and associated to the differ-
ent genomic regions (ncRNA, protein-coding genes, telom-
ers, intergenic) as defined by Ensembl. Crosslinks within
regions of protein-coding genes were further assigned to
5′UTR,ORF and 3′UTR. Peak enrichment analysis of TTP
binding sites was performed in iCount with the sum of
unique TTP crosslink sites identified in the different number
of independent experiments as previously described (34).
Briefly, 15 nucleotide windows flanking the crosslink site
were generated, 100 permutations were allowed and multi-
ple test correction of P-values (Benjamini-Hochberg) was
performed to calculate false-discovery rates (FDR). Only
TTP crosslink sites with aFDR lower than 0.05were further
considered in our analysis. Bed files summarizing iCLIP
mapped data for the groups of GFP–TTP (1) and GFP–
TTP-AA (2) upon 6 h Dox/1h LPS after peak enrichment
(FDR < 0.05) are provided as Supplementary Files 1 and
2.
For k-mer analyses, crosslinks associated to ncRNA or
3′UTR were considered separately. Prior to analysis, reads
in the antisense transcriptional direction were removed and
20 nucleotides windows were generated in both directions
10 nt far from each crosslink to finally assess frequency of
k-mer occurrency in a 100 nt-long windows (-50, +50). 100
randomized iCLIP positions present in the same genomic
feature were used to calculate the random mean score. Z-
score was calculated as the score frequency of a given 5-mer
occurrence normalized by the random mean score.
RNA maps were calculated after definition of ORF-
3′UTR and 3′UTR-intergenomic junctions in genome
mm10 (ensembl75 annotation) and after the generation of
windows with the 300 nt upstream and downstream each
junction. The position of TTP crosslink sites in each win-
dow is shown after normalization by the total number of
crosslinks and by all used junction spanning positions (to
correct for differences in length).
Raw data from RNASeq and RiboSeq was demulti-
plexed, FastQ analyzed and mapped to mm10 genome
(Mus musculus.GRCm38. 70 .gtf annotation) with TopHat
(v2.0.7) using tophat -p 6 -g 2 parameters. Differential gene
expression analysis was performed using DESeq2 1.6.3
package (46) and was adjusted to a negative binomial dis-
tribution after correction by library size factor before test-
ing for differential expression analysis, P-value determina-
tion and correction by using a Benjamini-Hochberg multi-
ple test to obtain final P-adjusted (padj) values. A multi-
factor design was used to account for the three different
conditions and for putative experimental batch effects [De-
Seq2 parameters: design(dds)← formula(∼ Library date +
Condition); nbinomWaldTest and Cooks filter off]. iCLIP,
RNASeq andRiboSeq data were either visualized in UCSC
genome viewer or in the Integrated Genome Browser (IGV)
to show read coverage and search for AU-rich elements
within 3′UTRs. Gene ontology (GO) analyses were per-
formed using GOrilla (47) whereas pathway enrichment
analysis was performed usingWebGestalt in which a hyper-
geometric statistical test followed by Benjamini-Hochberg
correction of the P-values was performed. Only pathways
with more than five genes were considered (48). Alterna-
tively, the gene set enrichment analysis tool (49) was used
to analyze gene sets of specific enriched terms.
Statistics for non-sequencing data
Values in bar graphs are shown as the mean of a minimum
of three measurements with their standard deviations. An
unpaired t-test was used where indicated. P-values <0.05
were considered significant.
RESULTS
Inducible expression of TTP and the phosphorylation site mu-
tant TTP-AA in TTP-deficient mouse macrophages
For the iCLIP analysis of TTP in macrophages, we gen-
erated a cell system that mimics the induction of TTP ex-
pression after inflammatory activation. Immortalized TTP-
deficient bone marrow-derived macrophages (BMDMs)
(20) were transduced using retroviral constructs, which har-
bor a GFP-fusion of wild-type murine TTP or a non-
MK2-phosphorylatable mutant of TTP (TTP-S52A, 178A
or TTP-AA) downstream of a doxycycline-inducible pro-
moter (Figure 1A). Both GFP–TTP and GFP–TTP-AA
were expressed with similar kinetics (Figure 1B) and to a
similar extent in these cells (Figure 1c) before and after
LPS stimulation, respectively. We analyzed the kinetics of
doxycycline/LPS-induced TTP and TTP-AA expression in
the transduced cells in comparison with LPS-induced in-
duction of TTP inRAW264.7 cells together with TTP’s sup-
pressive effects on TNF expression (Figure 1B and Sup-
plementary Figure S1). Treatment conditions for the trans-
duced macrophages (4–6 h doxycycline, 1 h LPS) resembled
TTP expression and phosphorylation in RAW264.7 mono-
cytes after ∼2 h indicating that we generated a functional
rescue system with basal TTP expression in doxycycline-
only treated cells (Figure 1B).
Next, we tested LPS-induced MK2-mediated phospho-
rylation of GFP–TTP and GFP–TTP-AA at S178, the only
site of TTP for which phosphorylation-specific antibodies
were available to us. Phosphorylation of GFP–TTP after
stimulation with LPS was detected by the multiple band
patterns and the shift to slower migrating bands (Figure
1C). Phosphorylation at S178 of GFP–TTP was detected
after 1h and sustained throughout 4 h of LPS stimulation,
but was not detected inmacrophages expressingGFP–TTP-
AA. Overall TTP phosphorylation (not only at S178), as
detected by a gel-shift in the anti-GFP immunoblot (Fig-
ure 1C), showed a maximum for the wild-type protein af-
ter 1h stimulation with LPS and was still detectable, but to
a lower extent after 4 h. The activity of the upstream ki-
nases p38MAPK andMK2 peaked after 1 h (Figure 1C). No-
tably, in GFP–TTP-AA expressing cells phosphorylation of
p38MAPK and MK2 was slightly increased and sustained
giving a first indication of a role for TTP phosphorylation
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Figure 1. Expression of TTP and TTP-AA inmacrophages and TTP-iCLIP. (A) Schematic representation of the all-in-one inducible vector pSERST11 that
allows the expression of GFP, GFP–TTP or GFP–TTP-AA upon addition of doxycycline. (B) Comparison of the TTP induction kinetics in RAW264.7
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in the feedback regulation of the LPS response. However,
here we cannot rule out that this effect could be also due to
induction of TTP-AA already 6 h before LPS stimulation
(Figure 1B).
iCLIP of TTP and TTP-AA
Weapplied a high-throughput sequencing approach, iCLIP,
to map the RNA-binding sites of both GFP–TTP and
GFP–TTP-AA at single nucleotide resolution before and
after macrophage stimulation with LPS. Effective immuno-
precipitation (IP) of the protein of interest is essential to
map RNA:protein interactions using iCLIP and since spe-
cific high-affinity TTP antibodies were not available, we
used Llama-derived nanobodies, which efficiently bind and
precipitate GFP-fusion proteins under both native and de-
naturing conditions (Supplementary Figure S2a) (44). Af-
ter RNase A digestion (Supplementary Figure S2b) TTP–
RNA complexes above 100 kDa were isolated and used for
iCLIP library preparations (Supplementary Figure S2c).
Genomic regions and RNA-binding motifs
First, we analyzed the distribution of TTP crosslink sites
mapped to distinct genomic features after 1h of LPS stim-
ulation. TTP bound to various genomic regions, such as
3′UTRs, ORFs, introns, intergenic regions and ncRNAs.
Interestingly, the binding of TTP to 5′UTRs of mRNAs
was rather rare. A remarkably increased association of TTP-
AAwith 3′UTRs compared to wild-type TTP was observed
(Figure 1D). Quantitation of TTP crosslink density enrich-
ment by normalization of the data to the total length of
the genomic features confirmed the increased association
of TTP-AA with 3′UTRs after 1 h LPS stimulation. It in-
dicated that both GFP–TTP and GFP–TTP-AA bound to
3′UTRs (and ncRNAs) with higher frequency, compared to
intronic and intergenic regions (Figure 1E). The increased
binding of TTP-AA to the 3′UTRs is specific for 1 h LPS
stimulation, whereas only minor differences between TTP
andTTP-AAbindingwere observed in untreated cells or af-
ter treatment with LPS for 4 h (Supplementary Figure S3),
a time when MK2 is inactive and overall phosphorylation
of TTP is decreasing (cf. Figure 1C). Taken together, these
findings indicate a specific and transient phosphorylation-
dependent suppression of TTP binding to the 3′UTR of its
mRNA targets and increased potential binding of phospho-
TTP to other genomic regions/features, such as ncRNAs.
We further determined the relative position of the TTP
crosslinks within the 3′UTRs. We found that the density of
crosslinks mapped to 3′UTRs increased by two fold when
compared to the density in ORFs (Figure 1F). The highest
density of crosslinks in the 3′UTRwas detected in the vicin-
ity of the polyadenylation signals (AAUAAA) (Figure 1F),
which are usually located∼20–30 nucleotides (nt) upstream
of the 3′ends of 3′UTRs (50).
Since iCLIP analysis is capable to determine the protein-
binding site with single nucleotide resolution directly from
the sequenced library, we determined the binding site se-
quence preferences of TTP andTTP-AA in the 3′UTR (Fig-
ure 1G). Interestingly, the frequency of TTP and TTP-AA
binding to specific RNA sequences clearly differs as seen
by the shape of the cloud and the indicated sequences of
the k-mer analysis performed for octameric binding motifs
(Figure 1G). After 1h of LPS treatment the most frequent
TTP-RNA crosslinking sites for TTP-AA were found to
correspond perfectly to the core of the ideal ARE UUAU-
UUAUU. In contrast, for wild-type TTP the frequency of
binding to these ARE-sites was lower and additional bind-
ing to G-rich patterns, such as UGUGUGUGU or GCU-
UCGGG, was observed in the 3′UTRs, indicating that the
phosphorylation of TTP may regulate its RNA-binding
properties to AREs in the 3′UTR.
Transcripts targeted by TTP and TTP-AA in macrophages
and HEK cells
Preserved RNA-binding of the non-phosphorylatable mu-
tant GFP–TTP-AA was reflected in the higher number of
RNA targets identified for this protein compared to the
number of wild-type GFP–TTP targets (Figure 1h). In total
3763 mRNAs with more than one crosslink in any genomic
feature were identified for GFP–TTP-AA, whereas the cor-
responding number for wild-type TTP was only 1112 (Sup-
plementary Data Set 1). RNA target comparison between
wild-type TTP and mutant showed an 85% to 97% overlap
depending on stringency, defined as the number of unique
cDNA counts associated to a TTP cross link site (Supple-
mentary Table S1). Comparison of our iCLIP datasets with
a previously published PAR-CLIP study for FLAG/HA-
tagged TTP in HEK293 cells (31), showed that 45% of the
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
cells with GFP–TTP- and GFP–TTP-AA expressing mouse macrophages after LPS stimulation for the indicated times. GFP–TTP and GFP–TTP-AA
expression was induced by pretreating the cells with doxycycline for 6 h prior to LPS addition. The arrow indicates the position of GFP–TTP-AA protein
while the lower band in the same bot is unspecific. (C) FACS-sorted GFP-positive cells were treated with either doxycycline alone for 6 h or in combination
with LPS for 1 and 4 h, were lysed and analyzed by western blot for the indicated proteins. (D) Transcriptome-wide distribution of crosslinks in RNAs
fromGFP–TTP and GFP–TTP-AA iCLIP experiments upon 6 h doxycycline induction in combination with 1 h LPS. Results from individual experiments
were grouped (GFP–TTP n = 4 and GFP–TTP-AA n = 3). The fraction of unique TTP crosslink sites mapped to the 3′ or 5′ untranslated region (UTR),
open reading frame (ORF), intergenic regions, introns or telomeric regions is presented as the percentage of the sum of unique cDNA counts (for peak call
analysis (false-discovery rate, <0.05)). (E) Density enrichment (by normalization of the data from (D) to the total length of the genomic features) for the
GFP–TTP- and GFP–TTP-AA-bound RNAs to the different transcriptome subsets after the indicated stimulation (GFP–TTP n = 4 and GFP–TTP-AA
n = 3). (F) The number of crosslinks in the sense (blue dots) and antisense direction (red dots) for the relative distance (-300 to 300) to the ORF-3′UTR
(left) and 3′UTR-intergenic junctions (right), respectively, are plotted and result in a smoothed distribution of crosslinks within this genomic feature (black
line). The insert shows a higher resolution of the smoothed distribution in the upstream 3′UTR. (G) Determination of the preferred GFP–TTP and GFP–
TTP-AA binding motifs upon 6 h doxycycline/1 h LPS stimulation by k-mer analysis. The k-mer-sequences of eight nucleotides in length with the highest
abundance are labeled in red. All groups were derived from four and three individual iCLIP analyses, respectively. (H) Overlap between GFP–TTP and
GFP–TTP-AA 3′UTR iCLIP targets and with TTP targets identified by PAR-CLIP (31). All targets with more than one cDNA count were considered.
Venn diagrams were generated using the eulerAPE v3 tool (84). The numbers of different targets in the groups are indicated.
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RNA targets identified by PAR-CLIP were also identified
as targets in the TTP-AA iCLIP dataset and only 15% of
these RNA targets were within our wild-type TTP iCLIP
dataset (Figure 1h). This suggests that the PAR-CLIP study
could have identified other-relevant mRNA targets specific
for HEK293 cells. The high percentage of mRNA target
overlap between GFP–TTP and GFP–TTP-AA indicated
that both wild-type and phospho-mutant proteins bind a
common set of targets, but possibly with different affinities,
which are modulated through MK2-dependent TTP phos-
phorylation. Indeed, the large number of targets unique for
GFP–TTP-AA in BMDMs treated with LPS for only one
hour indicated a marked down-regulation of target binding
by phosphorylation of the wild-type protein.
Global consequences of TTP- and TTP-AA-binding for the
myeloid transcriptome
Next, we analyzed the functional consequences of TTP
binding to its RNA targets in a global manner by relat-
ing iCLIP data to the global analysis of mRNA abun-
dance and translation after 1h of LPS-treatment, as mea-
sured by RNASeq and ribosome footprinting (termed Ri-
boSeq (51)), respectively. Figure 2A and Supplementary
Table S2 summarize the high-throughput sequencing ap-
proaches, their conditions and replicate numbers performed
in this study. Cluster analysis of RNASeq data showed a
distinct difference in the transcriptome of macrophages ex-
pressing mutant TTP-AA compared to those expressing
wild-type TTP (Figure 2B). In contrast, samples fromGFP-
only expressing TTP-deficient macrophages and GFP–TTP
expressing macrophages did not cluster separately as inde-
pendent groups (Figure 2B). This suggested a greater over-
all similarity of their transcriptomes and strongly supports
the notion that, following 1h of stimulation with LPS, in-
activation of wild-type TTP by phosphorylation liberates
mRNA targets from TTP-dependent regulation.
Similarly, global analysis of the change in mRNA
abundance and translation in TTP-deficient macrophages
(GFP controls) versus GFP–TTP expressing macrophages
showed no differences (Figure 2C and D). By contrast,
mRNA abundance and translation of TTP target mRNAs
was significantly decreased in macrophages expressing mu-
tant GFP–TTP-AA, compared to both GFP-only and
GFP–TTP expressing macrophages (Figure 2C and D).
This reveals an overall dependency of the de-repression
of translation on phosphorylation of TTP by MK2. We
observed that the global effect of the TTP-AA mutant
on mRNA abundance and translation was independent of
the abundance of the targets (data not shown). Impor-
tantly, global changes in the abundance and translation
of TTP mRNA targets could be linked to TTP and TTP-
AA binding to the 3′UTR, but not to the 5′UTR or the
ORF of the mRNAs (Figure 2E for abundance and 2F
for translation). This indicated that expression of a non-
MK2-phosphorylatable TTP mutant in macrophages re-
duced translation and/or abundance of its 3′UTR-bound
mRNAs in a global manner.
Differential expression (DE) analysis revealed a consider-
able overlap between mRNAs that are altered in abundance
and in translation, in all pair-wise comparisons performed
between the three conditions (GFP-only, GFP–TTP and
GFP–TTP-AA expressingmacrophages). The complete dif-
ferentially expressed gene analyses for RNASeq and Ri-
boSeq data can be found in the Supplementary Data Sets 2
and 3 and is summarized in Table 1. Generally we observed
the following major findings: (i) Changes in mRNA abun-
dance were more frequent (e.g. DE RNASeq, AA versus
TTP, 3774 genes) than in translation (e.g. DE RiboSeq, AA
versus TTP, 1070 genes) and ∼40% of the altered mRNAs
were found to be TTP targets in our iCLIP experiments
(Figure 2G, Table 1 and Supplementary Data Set 4). (ii)
The comparison between TTP and TTP-AA (right column
of Table 1) indicated that TTP phosphorylation is a land-
mark for post-transcriptional regulation of a large group of
mRNAs at the level of abundance (DE RNASeq only, AA
versus TTP, 2877 genes, 72.9% of all 3947 differentially ex-
pressed genes), while a smaller group of mRNAs is changed
in both, translation and abundance (DE RNASeq + DE
RiboSeq, AA versus TTP, 897 genes, 22.7%), and only a
small fraction of targets is exclusively regulated at the level
of RNA translation (DE RiboSeq only, AA versus TTP,
173 genes, 4.4%, Table 1). (iii) Of the 1681 iCLIP targets
differentially expressed between TTP-AA and TTP rescued
macrophages, 1133 (67.4%) are exclusively regulated in their
abundance (e.g. Mdm2), 444 (26.4%) are regulated at the
level of abundance and translation (e.g. Ier3) and 104 (6.2%)
are exclusively regulated in their translation (e.g. Ccl3).
Major TTP targets in LPS-stimulated macrophages and
their regulation by phosphorylation of TTP
The ability of TTP to regulate the pro-inflammatory
response by affecting TNF/NF-B-mediated signaling,
chemokine as well as MAPK signaling has been suggested
(24). Among the top 25 TTP mRNA targets (ranked by the
overall number of cross-links in the 3′UTR) (Table 2), well
known TTP-targets like TNF, C-X-Cmotif ligand 2 (Cxcl2)
or C-C motif ligand chemokine 3 (Ccl3) were identified and
serve as positive controls to validate our analysis (a compre-
hensive list of known TTP targets can be found in reference
(4)). However, novel or poorly characterized targets, such
as the E3 ubiquitin-protein ligase Mdm2, tumor necrosis
factor alpha-induced protein 3 (Tnfaip3, A20), C–C motif
ligand 4 (Ccl4), growth differentiation factor 15 (Gdf15) or
C–X–Cmotif ligand 10 (Cxcl10) are also part of the top list
(Table 2,marked in bold). Among the top targets of TTP, we
observe an over-representation of cytokines/chemokines,
including Cxcl10 and Gdf15. mRNAs encoding feedback
inhibitors of the inflammatory response, such as TNF,
Ier3 and Dusp1 (14), display significantly high numbers of
crosslinks in the 3′UTR (Table 2, selected targets). Most,
but not all of the top targets contain one or more ideal
AUUUA-motif repeat(s) in their 3′UTR (Table 2, middle
column). The transcripts without obvious AREs are indi-
cated in italics in Table 2.
The schematic representation of the combined iCLIP,
RNASeq and RiboSeq analyses of a known (TNF) and two
novel TTP-targets (Cxcl10 and Gdf15) are shown in Figure
3A–C. By comparing the iCLIP crosslinks of TTP andTTP-
AA in these genomic tracks, a significantly higher bind-
ing of TTP-AA to these transcripts is apparent. For all top
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Figure 2. Correlation of iCLIP, mRNA abundance (RNASeq) and translation (RiboSeq) to identify global consequences of TTP- and TTP-AA-binding
for the myeloid transcriptome. (A) Scheme for the correlations made between RNA levels or abundance (RNASeq), ribosomal occupation of mRNAs
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Table 1. Differential gene expression (DE) analyses of RNASeq and RiboSeq experiments. Cells were stimulated for a total of 6 h with doxycycline
combined with 1 h LPS (6 h Dox/1h LPS) for the last hour
DE analysis TTP versus GFP
TTP-AA versus
GFP
TTP-AA versus
TTP
DE genes [#] 1137 2390 3947
RNASeq [# of DE genes (% of all)] 1095 (96.3%) 2361 (98.7%) 3774 (95.6%)
RiboSeq [# of DE genes (% of all)] 208 (18.3%) 322 (13.5%) 1070 (27.1%)
RNASeq only [# of DE genes (% of all)] 929 (81.7%) 2068 (86.5%) 2877 (72.9%)
RNASeq and RiboSeq [# of DE genes (% of all)] 166 (14.6%) 293 (12.3%) 897 (22.7%)
RiboSeq only [# of DE genes (% of all)] 41 (3.6%) 29 (1.2%) 173 (4.4%)
DE and iCLIP [#/%] 435 (38.3%) 1034 (43.3%) 1681 (42.6%)
DE and iCLIP target in RNASeq [#/%] 419 (96.3%) 1014 (98.1%) 1577 (93.8%)
DE and iCLIP target in RiboSeq [#/%] 90 (20.1%) 157 (15.2%) 548 (34.7%)
DE and iCLIP target in RNASeq only [#/%] 350 (80.5%) 877 (84.8%) 1133 (67.4%)
DE and iCLIP target in both [#/%] 69 (15.9%) 137 (13.3%) 444 (26.4%)
DE and iCLIP target in RiboSeq only [#/%] 20 (4.6%) 20 (1.9%) 104 (6.2%)
The number of differentially expressed (DE) genes in each group, their overlap within the two groups and their overlap with the iCLIP occurrences were
calculated and are given as absolute numbers and percentages in relation to all DE genes and all DE iCLIP targets, respectively.
3′UTR targets binding of GFP–TTP-AA to target 3′UTRs
was more frequent compared to GFP–TTP (Table 2, right
column). This could reflect the phosphorylation-dependent
release of TTP, but not of TTP-AA, from the AREs after
1h of LPS stimulation.
The association of TNF, Cxcl10 and Gdf15
mRNA to TTP was additionally confirmed by RNA-
immunoprecipitation (RNA-IP) experiments after 1 h of
LPS treatment (Figure 3A–C and Supplementary Figure
S4a). The relative enrichment of mRNAs in GFP–TTP-
and GFP–TTP-AA-IP compared to their presence in
control GFP-IP is shown in the right panels of Figure
3A–C. Enrichments (20- to 4000-fold) were obtained in the
RNA-IP experiments for all three mRNAs confirming the
TTP-binding detected in iCLIP. In all cases, GFP–TTP-
AA precipitation recovered significantly more transcript
than GFP–TTP, again indicating stronger binding of the
non-phosphorylated TTP. In addition we also analyzed
the functional properties of target 3′UTRs in luciferase
reporter experiments. The insertion of the 3′UTRs of
Cxcl10 and Gdf15 mRNA into the reporter plasmid
strongly reduced reporter activity (Supplementary Figure
S4b). Co-expression of GFP–TTP or GFP–TTP-AA led to
a further reduced reporter activity (Supplementary Figure
S4c). Polysome analyses showed that TTP and TTP-AA
not only regulate the association of TNF mRNA, but
also of Gdf15 mRNA to actively translating ribosomes.
Association of Cxcl10 and of -Actin mRNA remained
unaffected (Supplementary Figure S5a-c). The mRNA of
-Actin was in the list of top iCLIP targets, but has no
ARE in its 3′UTR (Table 2) and no effect on its abundance
was detected after TTP-expression (data not shown). We
therefore considered -Actin mRNA as a negative control
for TTP binding.
Since the novel TTP-target Cxcl10 is a secreted cytokine
of the chemokine family (52), we furthermonitored its TTP-
dependent expression. The results indicated a strong effect
of both TTP and TTP-AA on Cxcl10 mRNA level (Figure
3D) and protein synthesis (Figure 3E) showing that TTP
binding to AREs in the 3′UTR of Cxcl10 is influencing the
post-transcriptional regulation of this cytokine only at the
level of mRNA abundance, because we did not observe ob-
vious changes in polysome association of its mRNA (Sup-
plementary Figure S5c).
Phosphorylation-dependent TTP inactivation is required for
NF-B-signal transduction
Next, we performed gene ontology (GO) analyses using the
DE RiboSeq datasets to identify TTP-dependent transla-
tional RNA regulons. The analysis revealed commonly reg-
ulated groups of transcripts based on the biological pro-
cess they are involved in (Table 3). After removal of re-
dundant GO terms, we identified ‘immune response’, ‘cell
death’, ‘response to stimulus’ and ‘signal transduction’ as
terms designating mRNAs commonly regulated by TTP-
phosphorylation in LPS-stimulated macrophages (Figure
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
(RibosSeq) and the iCLIP data. RNASeq and RiboSeq measurements were performed in triplicate for each GFP-protein. See Supplementary Table S1
for number of replicates and conditions. (B) Cluster analysis for the RNASeq samples. Three replicates of cells each expressing GFP/EV, GFP–TTP or
GFP–TTP-AA following 6 hDox/1h LPS, are numbered 1, 2 and 3. (C andD) Overall changes in mRNA abundance (RNASeq (c)) andmRNA translation
(RiboSeq (d)) between the indicated genotypes comparing the following TTP targets: iCLIP targets (white boxes) and non-bound mRNAs (gray boxes) are
shown as a kernel density distribution in boxplots. AWilcoxon rank sum test with continuity correction was used to determine the P-values shown for each
comparison. Statistically significant differences in abundance and translation between targets and non-targets are indicated in red. For each genotype n =
3 sequencing libraries were analyzed and the mean of each group is shown. The red lines indicate for y = 0. Highly statistically significant differences are
indicated in red. (E and F) For the comparisons between TTP/GFP and TTP-AA/GFP changed targets obtained from (C) and (D) were assigned to the
mRNA region (5′UTR, ORF and 3′UTR) leading to detailed (E) RNASeq and (F) RiboSeq blots. A Wilcoxon rank sum test with continuity correction
was used to determine the P-values shown for every comparison. The red lines indicate for y = 0. Highly statistically significant differences in abundance
(E) and translation (F) between targets (white boxes) and non-targets (gray boxes) are indicated in red and could only be detected for targets where TTP
binds in the 3′UTR. (G) The overlap of DE genes from RNASeq and RiboSeq experiments is visualized by Venn diagrams for the different comparisons.
The number of genes for the RNASeq (changes in mRNA abundance), RiboSeq (changes in translation) and RNASeq/RiboSeq (changes in abundance
and translation) are given together with the number of iCLIP targets in each group (in brackets).
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Figure 3. Examples of established and novel TTP targets identified by iCLIP and their validation by RNA-IP and expression analysis. (A–C) Genomic
tracks for TNF (A), Cxcl10 (B) and Gdf15 (C) are shown, containing information for iCLIP, RNASeq and RiboSeq for GFP-, GFP–TTP- and GFP–TTP-
AA-expressing cells. ATTTA and TATTTAT repeats are indicated as red dots below the iCLIP tracks. Dimensions are indicated by the numbers in brackets
for each track. At the right of the tracks, RNA-IPs for GFP–TTP and GFP–TTP-AA are shown in relation to the GFP/EV control IP. The asterisk (*)
indicates P-values ≤ 0.05 for GFP–TTP-AA IP compared to GFP–TTP IP. (D) Cxcl10 mRNA level in the three different cell lines were determined by
qPCR. (E) Cxcl10 protein levels were determined by ELISA for the indicated stimulatory conditions. 1 × 104 cells were seeded in triplicates in a 96-well
plate. After attachment of the cells, stimulation was started and Cxcl10 protein in supernatants was measured. The asterisk (*) indicates P-values ≤ 0.03;
n.d.: not detectable.
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Table 2. List of the top 3′UTR target mRNAs and other selected TTP iCLIP targets of the GFP–TTP/GFP–TTP-AA group upon 1h LPS stimulation in
combination with a total of 6 h doxycycline induction
Top 3′UTR targets – 6 h Dox/1h LPS
Target mRNA 3′UTR length [nt] AUUUA clusters cDNA counts TTP–AA/TTP counts
Cxcl2 705 11 2771 9.96
Tnf 762 8 2412 2.30
Mdm2 1221 8 1716 10.87
Actb 681 0 1431 3.59
Ccl3 407 5 1187 3.84
Ccl2 275 1 993 11.27
Ccl4 302 2 956 13.22
Ybx3 577 2 946 5.98
Tnfaip3 6184 5 753 12.07
Nfkbia 509 2 729 11.22
Lpl 2644 5 640 6.00
Spp1 432 2 568 4.71
Cxcl10 1052 3 567 42.23
Cdkn1a 1329 3 544 10.61
Nlrp3 693 5 538 1.74
Lars2 986 0 516 n.d.
Plau 938 2 505 16.38
Pfn1 272 1 485 5.90
B2m 448 1 467 15.74
Sdc4 1653 0 465 7.56
Tnfsf9 253 2 462 16.50
Icam1 851 4 427 19.00
Tmsb4x 406 0 418 14.52
Nfkbiz 1353 4 403 31.25
Gdf15 148 5 384 3.03
Selected targets
Ier3 601 5 255 2.3
Dusp1 696 4 291 2.5
4A). When differentially expressed genes fromRNASeq ex-
periments (Supplementary Table S3) or the list of TTP-
bound mRNAs (data not shown) were used, similarly en-
riched pathways as highlighted in Figure 4A were un-
covered. The gene signature of differentially expressed
and translated iCLIP target mRNAs was associated with
TNF/NF-B-signaling (Supplementary Data Set 5) and
the inflammatory response. Interestingly, GFP–TTP-AA
expressing cells showed an increase in mRNA abundance
and translation of mRNAs associated to TNF/NF-B-
signaling when compared to GFP–TTP cells at 1h LPS
stimulation (Figure 4B). Approximately 50% of the DE
genes associated with these pathways were also identified
as TTP targets in our iCLIP experiments, strengthening the
notion that TTP acts as a global regulator of the abundance
and translation of mRNAs involved in signal transduction
during the inflammatory response. By contrast, no signif-
icant changes in the inflammatory response gene signature
were found when comparing TTP-expressing cells andGFP
control cells (data not shown), again suggesting a similarity
between macrophages that lack TTP and those that contain
wild-type TTP during the early stages of LPS-dependent
cell activation.
Next, we validated potential alterations in the TNF/NF-
B-signaling pathway, the inflammatory response and the
prolonged activation of p38MAPK andMK2 in LPS-induced
signaling (Figure 4C). As expected from our pathway en-
richment analysis, we did not observe differences in cellu-
lar signal transduction between TTP-deficient and TTP-
expressing macrophages. However, macrophages express-
ing the TTP-AA mutant displayed profound alterations in
both NF-B- and p38MAPK/MK2-signaling. Phosphoryla-
tion of the p38MAPK-signaling proteins was significantly de-
layed (Figure 4C, and Figure 1C), whereas phosphoryla-
tion of NF-B (p65) was decreased, but prolonged (Fig-
ure 4C, and quantified in Supplementary Figure S6a). Up-
stream components of the NF-B-signaling module such
as IKK/ and IB showed a similarly delayed and de-
creased activation pattern (Figure 4C). As phosphorylation
of NF-B ultimately leads to its nuclear translocation and
transcriptional activation of responsive genes (summarized
in (53)), we investigated whether the delayed phosphoryla-
tion kinetics also results in impaired nuclear translocation.
Nuclear NF-B becomes detectable shortly after LPS stim-
ulation in all of the three cell types (Supplementary Figure
S6b). By calculating the nuclear to cytosolic ratio of NF-B
protein at each time point, we detected a decreased and de-
layed translocation of p65/ NF-B in both, TTP-AA- and
TTP-expressing cells, compared to GFP-only cells (Supple-
mentary Figure S6c). To validate this effect more quanti-
tatively, we quantified fluorescence signals in cytosolic and
nuclear compartments (Figure 4D and E). Expression of
GFP–TTP and GFP–TTP-AA slowed down NF-B nu-
clear import and we observed an increased effect in GFP–
TTP-AA cells, which was in line with the observationsmade
by cellular fractionation and immunoblotting (Figure 4C).
The delayed NF-B translocation is paralleled by global
changes in cytokine expression in these cells (Supplemen-
tary Figure S7). This may at least in part reflect functional
consequences of the alteration in NF-B signaling. Clus-
ter analyses of both RNASeq and RiboSeq data showed al-
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Figure 4. Gene ontology analysis reveals a role of TTP in signal transduction processes includingNF-B -signaling. (A) Differentially expressed genes from
RiboSeq data comparing different samples were used to perform gene ontology (GO) analyses using the GOrilla tool (47). To remove redundant terms and
to visualize the results the REVIGO tool (85) was used. The y-axis (semantic space), that quantifies similarities of word meanings. The color-coded log10
P-values for each GO term are given on the x-axis. Circle sizes correspond to the frequency of similar GO terms summarized in the specific GO term (see
legend on the right). Enriched GO terms connected to enriched pathways (Table 3) are highlighted in red rectangles. (B) A custom gene set comprised of
117 TNF-/NF-B-signaling-related genes and the ‘inflammatory response’ (GO:0006954) were enriched for TTP-AA vs. TTP cell mRNA expression (left
plot) and translation (right plot). Log2-fold changes in expression and translation of each regulated gene are plotted with the corresponding adjusted P-
values (padj) of the changes. Numbers indicate increased or decreased genes. The associated numbers in brackets show the number of iCLIP targets in each
corresponding group. (C) Components of the NF-B-signaling pathway were analyzed in western blot in macrophages upon 6 h of doxycycline-stimulation
prior to stimulation with LPS for the indicated times. In addition, the phosphorylation of p38MAPK at T180/T182 andMK2 at T222 (double band pattern
indicated by arrows) were monitored as controls for LPS-mediated TLR4-activation. Quantifications of these western blots are given in Supplementary
Figure S6. (D) Examples of images used for the microscopic analysis of NF-B localization (green) in the indicated cell types and upon different times of
LPS stimulation. Nuclei (blue) and F-actin (red) were co-stained with DAPI and Phalloidin, respectively. An overlay of all three channels is added to each
panel. (E) Quantitative analysis of the images exemplified in (D) to compare the increase of nuclear and decrease of cytosolic NF-B localization upon
LPS stimulation. For each analysis and each genotype, unstimulated cells were used as a reference. Nuclear localization was assessed by comparing with
DAPI and cytosolic localization with F-actin co-staining (see experimental procedures for details). The hashtag (#) indicates statistical significance with
P-values ≤ 0.05 comparing GFP–TTP-AA to GFP/EV and GFP–TTP cells, whereas the asterisk (*) indicates for significance comparing GFP–TTP with
GFP/EV cells.
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Table 3. Enriched pathways determined byWebGestalt for the differentially expressed genes obtained from the RiboSeq data for cells expressing GFP/EV
(GFP), GFP–TTP (TTP) or GFP–TTP-AA (AA) upon 6 h Dox/1 h LPS treatment
1. RiboSeq TTP versus GFP
Pathway Name
# reference
genes
#DE genes/
# iCLIP targets
adjusted
P-value
PluriNetWork 292 8/7 3.39E-5
mRNA processing 483 9/6 9.93E-5
Focal Adhesion 186 5/4 0.0006
2. RiboSeq TTP-AA vs. GFP
Apoptosis 93 6/4 0.0001
Myometrial Relaxation and Contraction Pathways 158 7/3 0.0001
miRNA regulation of DNA Damage Response 69 5/2 0.0001
Calcium Regulation in the Cardiac Cell 152 7/2 0.0001
Glycolysis and Gluconeogenesis 51 5/3 0.0001
Chemokine signaling pathway 186 6/1 0.0018
T Cell Receptor Signaling Pathway 143 5/5 0.0019
Wnt Signaling Pathway NetPath 141 5/1 0.0019
PluriNetWork 292 7/5 0.0019
TNF-alpha NF-kB Signaling Pathway 215 6/4 0.0019
3. RiboSeq TTP-AA vs. TTP
mRNA processing 483 42/28 7.5E-15
PluriNetWork 292 31/23 1.68E-13
TNF-alpha NF-kB Signaling Pathway 215 26/18 8.01E-13
Chemokine signaling pathway 186 21/10 6.24E-10
Macrophage markers 10 7/2 9.22E-10
Apoptosis 93 15/9 1.59E-9
Focal Adhesion 186 18/14 1.02E-7
Adipogenesis 133 15/10 1.88E-7
Myometrial Relaxation and Contraction Pathways 158 16/11 2.7E-7
G Protein Signaling Pathways 94 12/7 6.88E-7
terations in cytokine mRNA levels in cells expressing the
mutant TTP-AA, as compared to the other two cell types.
Discrete clustering of the three individual replicates of TTP-
AA cells (AA1-3) was observed in these analyses, whereas
replicates ofGFP- andTTP-expressing cells failed to cluster
based on the expression of wild type TTP (Supplementary
Figure S7).
In summary, the predictions from our high-throughput
sequencing data analysis, indicating that MK2-dependent
inactivation of TTP is required for signal transduction, were
validated. By phospho-kinetic analyses we showed that in
macrophages the post-translational regulation of TTP is re-
quired for proper LPS-stimulated NF-B phosphorylation
and for its translocation to the nucleus to trigger the cy-
tokine response.
TTP limits the expression of feedback inhibitors
The identified target mRNAs of TTP, coding for feed-
back inhibitors of the inflammatory response such as
Tnfaip3/A20 (17), Ier3 (14,54–55) or Dusp1 (56), as well as
TNF itself (summarized in (57,58)), are closely connected
to NF-B-activation. Thus, we hypothesized that the ex-
pression and translation of mRNAs encoding feedback in-
hibitors of the inflammatory response were controlled by
TTP. Genomic tracks for Tnfaip3, Ier3 and Dusp1 show
TTP and TTP-AA binding to AREs within their 3′UTRs
(Figure 5a-c left), which is confirmed by RNA-IP (Figure
5A–C right). Similar to TNF, Cxcl10 and Gdf15 mRNA
(Figure 3A–C), we observedmore crosslinks of TTP-AA for
Dusp1, Ier3 and Tnfaip3 representing a potential stronger
binding of mutant TTP compared to the wild-type protein.
This conclusion is further supported byRNA-IPs capturing
these mRNAs more effectively with GFP–TTP-AA. Anal-
ysis of the mRNA levels of the targets Dusp1, Ier3, and Tn-
faip3 by RT-qPCR confirmed that TTP and TTP-AA ex-
pression reduced mRNA abundance of all transcripts upon
macrophage stimulation with LPS (Figure 5D). Whereas
wild-type and mutant TTP affected Dusp1 mRNA to sim-
ilar extend, TTP-AA had greater impact on Ier3 and Tn-
faip3 mRNA levels. A similar reduction was observed for
the TTP’s bona fide target TNF, that itself is amember of the
feedback inhibitor group (Supplementary Figure S1f). To
demonstrate the link TTP of binding to decreased expres-
sion, the 3′UTR of Tnfaip3 mRNA was inserted into a lu-
ciferase reporter. This led to decreased luciferase expression
(Supplementary Figure S4d). Further TTP-dependent re-
duction of luciferase expression was observed, without any
additional effects of the TTP-AA mutant (Supplementary
Figure S4e).
Analysis of mRNA translation of both feedback in-
hibitors of the inflammatory response and components of
the NF-B-signal transduction pathway, such as Nfkbia,
Nfkbib, Nfkbid, Nfkbie and Nfkbiz, revealed that many
of these TTP-targeted mRNAs were translationally dereg-
ulated at 1h of LPS stimulation in macrophages expressing
the mutant TTP-AA (Figure 5E). Further analysis of pro-
tein abundance of feedback inhibitors Dusp1, Ier3, Tnfaip3
and TNF by western blot revealed that expression of TTP
and TTP-AA reduced the level of these proteins (Figure
5f, Supplementary Figure S1h). For TNF and Ier3 we ob-
served reduced protein levels in TTP-AA cells, when com-
pared to wild-type TTP-expressing cells (Figure 5F, Sup-
plementary Figures S1 and S8). Of note, the protein level
reduction in macrophages expressing TTP or TTP-AA was
not only due to a potential destabilization of TTP-targeted
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Figure 5. Deregulation of feedback inhibitors of inflammation through TTP and TTP-AA. (A–C) Genomic tracks for the feedback inhibitors Dusp1
(A), Ier3 (B) and Tnfaip3 (C) containing information for iCLIP, RNASeq and RiboSeq data for GFP-, GFP–TTP- and GFP–TTP-AA-expressing cells
are shown in the format as introduced in Figure 3. ATTTA and TATTTAT repeats are indicated below the iCLIP tracks. Dimensions are indicated by
the numbers in brackets for each track. The graph to the right of each track shows the RNA-IPs for GFP–TTP and GFP–TTP-AA in relation to the
GFP/EV Control IP. Asterisks (*) indicate P-values ≤ 0.05 for GFP–TTP-AA IP compared to GFP–TTP IP. (D) Relative mRNA levels of the indicated
transcripts were determined by qPCR upon different stimulations. The control conditions of GFP/EV-expressing cells were set to 1. Fold changes were
calculated in relation to this condition. (E) Log2-fold changes in translation versus changes in mean expression (log10) for a set of feedback inhibitors of
the inflammatory response (14) and selected other mRNAs in GFP–TTP-AA- versus GFP–TTP-expressing cells. The position of individual transcripts is
marked. TTP-bound iCLIP target mRNAs are shown as red dots, whereas non-targets are black. (F) Levels of the Dusp1-, Ier3- and Tnfaip3-protein were
determined by western blot in the TTP BMDM cell lines upon different stimulations. GAPDH served as a loading control. Quantifications of western
blots are given in Supplementary Figure S8.
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mRNAs (Figure 5D), but could also be explained by less
effective polysome association of the these target mRNAs
(Supplementary Figure S5b and d). The strongest trans-
lational repression was observed for Ier3 and TNF at all
times of LPS stimulation and mild effects were observed
for Dusp1 and Tnfaip3 at different times of LPS stimu-
lation (Supplementary Figure S5d). Taken together, our
data suggest that TTP is required for the precise modula-
tion of the pro-inflammatory response to LPS. It functions
by directly binding to the 3′UTR of components of the
TNF/NF-B-mediated signaling and post-transcriptional
regulation of feedback inhibitors of the inflammatory re-
sponse, such asDusp1, Ier3, Tnfaip3 and TNF.Of note, this
TTP-dependent regulation is not specific for macrophages
and was also confirmed in fibroblasts (Supplementary Fig-
ure S9).
TTP phosphorylation by MK2 prevents cell death
Deregulation of NF-B-signaling is associated with al-
tered inflammatory responses and macrophage cell death
(summarized in (53,59)). Our gene set enrichment anal-
ysis of changes between TTP-AA- and TTP-expressing
macrophages highlighted cell death as a pathway that was
deregulated. Characterization of a set of 65 genes related to
apoptosis showed that 21 genes (including 15 iCLIP targets)
were differentially increased at the level of mRNA abun-
dance and 14 genes (seven iCLIP targets) showed enhanced
translation in TTP-AA macrophages compared to TTP
macrophages (DESeq2, padj<0.05, Figure 6A). 11 out of
these 14 genes showed a significant change in both mRNA
abundance and translation. Within this group of 11 genes
we identified several pro-apoptotic genes, such as Bbc3,
Pmaip1, Tnfrsf1a, Bak1 and Casp4 (DESeq2, padj<0.05,
Figure 6A). Three genes with increased mRNA translation
in TTP-AA expressing macrophages and with relation to
cell death were the pro-apoptotic genes Bcl2l11, Cdkn2a
and Fas. All these mRNAs, except Fas and Bak1, were iden-
tified as TTP targets in our iCLIP experiments suggesting
that MK2-mediated modulation of TTP activity is involved
in the control of cell survival.
Analysis of the growth and viability of TTP-rescued
macrophages by a WST-1 assay showed that an artificial
long-term induced expression of GFP–TTP only moder-
ately reduced viability and proliferation of macrophages
compared to GFP-only control cells (Figure 6B). Inter-
estingly, in the same system the expression of GFP–TTP-
AA was strongly anti-proliferative and reduced the viabil-
ity of cells to 50% after 20h of doxycycline treatment (Fig-
ure 6B). This suggested a potential role for TTP in cell cy-
cle regulation as proposed for the other two Zfp36 family
members Zfp36l1 and Zfp36l2 (60). Analysis of apoptosis
by 7-amino-actinomycin D (7-AAD) incorporation showed
that induction of GFP–TTP-AA expression with doxycy-
cline increased the number of apoptotic cells over time,
whereas expression of GFP and GFP–TTP had no effect
(Figure 6C). Quantitation of GFPmean fluorescence inten-
sities in 7-AAD+ and 7-AAD− cells demonstrated that ex-
pression of GFP–TTP-AA significantly correlated with cell
death (Figure 6D). Finally, we also measured cell suscep-
tibility to LPS-induced apoptosis. It was seen that GFP–
TTP-AA expression significantly increased cell death com-
pared to macrophages expressing GFP–TTP or GFP. Only
TTP-deficient cells were protected against LPS-induced cell
death for up to 24 hours (Figure 6e). Altogether, our results
indicated that TTP phosphorylation by MK2 was required
for TTP inactivation and preserved macrophages from cell
death after LPS stimulation.
DISCUSSION
The present study identifies in vivo targets of TTP and
characterizes the function of TTP in LPS-stimulated
macrophages, a TLR4-expressing cell type, where TTP
shows major expression and plays a prominent regulatory
role in the control of the inflammatory response (61). By
using iCLIP to identify TTP targets and relating TTP-
binding to TTP-dependent changes of mRNA abundance
and translation, we provide a transcriptome-wide view of
the regulation of TTP-bound RNAs. TTP is able to post-
transcriptionally regulate its mRNA targets either by con-
trolling RNA-stability and/or by regulating mRNA trans-
lation. TTP-action in coordinating a rapid and transient in-
flammatory response (62) is effectively regulated through its
transient phosphorylation byMK2 (Figure 7A). Therefore,
a mutant of TTP, which is not phosphorylated by MK2,
displays enhanced binding to 3′UTRs of mRNA leading to
deregulation of both the kinetics and the endpoints of the
inflammatory response. These observations corroborate the
findings reported for in vitroMK2-phosphorylated TTP (8).
TTP not only regulates cytokine- and chemokine-coding
transcripts, but also transcripts of essential feedback in-
hibitors of the inflammatory response. In the case of the
TTP mutant, where phosphorylation-dependent regulation
of TTP is defective, we observed a deregulation of NF-B-
signaling due to the post-transcriptional control of NF-
B-regulators. Similar to the results presented here, TTP-
regulated RNAs identified in a MEF cell system and com-
parisons with analyses in human cells (see (31)) will enable
us to further determine cell-type and stimulus-specific bind-
ing of TTP to RNAs.
Here we have identified 1112 mRNA targets of TTP and
3763 mRNA targets of TTP-AA in macrophages by iCLIP,
which considerably extends the number of targets previ-
ously identified in a PAR-CLIP study that employed over-
expressed FLAG/HA-tagged TTP in HEK293 cells (31),
which do not carry TLR4 receptors and do not respond
to LPS stimulation (14). Importantly, the TTP-AA mu-
tant protein gave rise to more complex iCLIP libraries
from a highly diverse pool of mRNA targets resulting in
a higher abundance of unique cross-link sites compared
to wild-type TTP. Both, TTP and TTP-AA displayed a
strong association to AUUUA core motif-containing se-
quences in the 3′UTR of mRNAs, consistent with previous
studies that determined the optimal TTP-binding sequence
UUAUUUAUU (summarized in (4)). TTP-AA showed an
even higher 3′UTR-enrichment thanwild-type TTP and po-
tentially a higher bias towards optimal AREs and its vari-
ants, symbolized as WWW(AUUUA)WWW (W could be
A or U). These binding preferences reflect the ability of the
individual zinc fingers of TTP to bind to UAUU, and ex-
actly revealed the octamer UAUUUAUU that was identi-
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Figure 6. TTP-AA-expression limits proliferation and increases cell death. (A) The 65 genes of the enriched Wiki pathway ‘Apoptosis’ (WP1254 69153)
were analyzed for changes in their expression (left panel) and translation (right panel) comparing GFP–TTP-AA to GFP–TTP cells. Log2-fold changes are
plotted against the adjusted P-values of the changes. The numbers of up- and down-regulated genes are given (number of iCLIP targets in brackets). (B)
Cell proliferation of macrophages after induction of GFP, GFP–TTP and GFP–TTP-AA expression by doxycycline treatment. Non-doxycycline treated
cells of each genotype were used for normalization of signals. The mean of all three measurements is shown and standard deviations are included. The
asterisk (*) indicatesP-values≤ 0.05. (C) Percentages of apoptotic cells upon long-term expression of GFP-fusion proteins were determined. Themean and
standard deviation of three independent experiments are shown. The asterisk (*) corresponds to P< 0.03. (D) Mean fluorescence intensities (MFI) of GFP
fluorescence in apoptotic (7-AAD+) and non-apoptotic (7-AAD-) GFP–TTP-AA-expressing cells. P < 0.1×10−6 (unpaired t-test). (E) Cell death after
induction of GFP/GFP–TTP/GFP–TTP-AA expression and LPS stimulation for different times. The mean and standard deviation of three independent
experiments s are shown. The asterisk (*) corresponds to P < 0.005.
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Figure 7. Schematic presentation of TTP’s action as phosphorylation-triggered key regulator of feedback control of inflammation via NF-B-regulating
proteins, cytokines and chemokines. (A) Upon LPS-mediated TLR4-stimulation (1 h LPS), TTP is phosphorylated and thereby inactivated by MK2. As
a consequence and as detected by iCLIP analyses, binding to AREs within 3′UTRs is decreased, compared to non-phosphorylated TTP (no LPS) or at
later time points when TTP phosphorylation decreases (4 h LPS). Under physiological conditions, phosphatases (PPs), such as PP2A, are responsible for
dephosphorylation of TTP after prolonged LPS challenge, restoring TTP’s binding to AREs to mediate post-transcriptional control of associated mRNAs.
An enhanced association of phospho-TTP to ncRNAs was also detected without determining its physiological role. (B) Absence of MK2-mediated TTP-
phosphorylation at serines S52/S178 in TTP-AA cells results in enhanced binding to AREs in the 3′UTRs of mRNAs coding for stimulators and feedback
regulators of inflammation especially after 1h of LPS stimulation. This results in their post-transcriptional regulation at the level of mRNA stability and
translation. As a direct output we detected a stronger suppression of stimulatory cytokines and chemokines, such as TNF, Cxcl10 and Gdf15, and of
negative feedback inhibitors, such as Ier3, Dusp1 and Tnfaip3, in these cells, compared to wild-type TTP-expressing cells. In addition, several proteins
coding for NF-B-regulators are affected post-transcriptionally. Together this results in deregulated NF-B-signaling and increased cell death in response
to LPS. ARE: AU-rich element; Cap: 5′-7-methylguanosine cap; CDS: coding (DNA) sequence; (A)n: 3′-poly(A) tail.
fied as the binding motif of the tandem zinc finger domain
in the TTP structure (63). For wild-type TTP we also iden-
tified exceptions of the classic binding motif. These G-rich
sequences may reflect alternative binding modes of MK2-
phosphorylated TTP. Additionally, our iCLIP data showed
a rather uniform distribution of crosslinks within 3′UTRs.
A linear increase of crosslinks was only observed within the
first 100 nucleotides following the ORF-3′UTR junction.
Apart from this, we found a random distribution of TTP-
binding sites in 3′UTRs, which corresponds to the random
distribution of AREs in this gene region (64). However, a
clear enrichment of crosslinks was observed at the 3′UTR-
intergenic region junction, indicating a preferential 3′UTR
binding with maximal enrichment at about 70 nucleotides
upstream of the ends of the 3′UTRs. It was previously pro-
posed that TTP-binding is enriched near the very 3′ends of
3′UTRs (31), supporting the physiological role of TTP in
deadenylation of mRNAs (11–13). Alternatively, this could
also reflect a role of TTP in polyadenylation (65).
We found that iCLIP targets are regulated at the level
of mRNA abundance and to a much lower extent at the
level of translation. In particular, GFP–TTP-AA cells dis-
play the most prominent degree of regulation after 1 hour
of LPS treatment indicating the physiological role of TTP
phosphorylation in macrophages at a global level. This is
also reflected by the loss of differences in 3′UTR binding
without or with long-term LPS stimulation. Generally, for
most changes in mRNA translation simultaneous changes
in mRNA levels were observed, a finding that is consis-
tent with previous studies of LPS-stimulated macrophages
(14,66). Around 80% of all differentially expressed RiboSeq
iCLIP targets are also differentially expressed in RNASeq
analyses (TTP-AA vs. TTP, 448 of total 548). Most of the
iCLIP targets are only regulated at the level of mRNA sta-
bility. This group of iCLIP target mRNAs is represented by
around 94% (TTP-AA vs. TTP, 1592 of total 1692) of all
differentially expressed genes that appear in the RNASeq-
only group. Hence, next to the identification of its numer-
ous targets we add a systemic view of the consequences of
phosphorylation-regulated RNA-binding of TTP to target
mRNAs.
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In addition to known TTP targets that confirmed the ex-
perimental approach, other novel or poorly characterized
targets of TTP such as Cxcl10 or Gdf15 were identified by
iCLIP. Cxcl10 mRNA contains two pentameric AUUUA
motifs in its 3′UTR that could serve as TTP-binding sites
and yielded in a significant number of crosslinks in our
analysis. Suppression of Cxcl10 mRNA and protein lev-
els by TTP, confirmed that it is a true TTP target. Previ-
ously it was suggested that TTP-deficiency does not influ-
enceCxcl10mRNA levels (67). Another report documented
p38MAPK/MK2-dependency of Cxcl10 levels, although this
was found in the context of IFN- stimulated macrophages
(52). The reason for these divergent results is not clear but
could arise from analysis at different times and modes of
stimulation. Further evidence is provided by the TTPaa/aa-
mouse-model where both, Cxcl10 mRNA and protein were
decreased in vivo (26). Similar to Cxcl10, Gdf15 was only
poorly characterized as a target of TTP. Gdf15 was ini-
tially described as macrophage inhibitory cytokine (MIC-
1) able to reduce TNF expression (68). Consequently it was
reported that Gdf15 functions as an anti-inflammatory ef-
fector by reducing the recruitment of leukocytes to sites of
inflammation. The authors suggested thatGdf15 could gen-
erally function in inflammatory diseases and cancer (69).
We detected crosslinks of TTP and TTP-AA to AREs in
the 3′UTR of Gdf15 mRNA. Taken together, these obser-
vations support our suggestion that Gdf15 and Cxcl10 are
novel direct targets of TTP in LPS-stimulatedmacrophages.
Additionally, we observed the regulation of inflamma-
tory feedback inhibitor mRNAs, such as those of Dusp1,
Ier3 and Tnfaip3 (or A20) with Tnfaip3/A20 being a
poorly characterized TTP-bound mRNA. Binding of TTP
and TTP-AA to AREs within 3′UTRs of the mRNAs re-
duced their protein level through mRNA destabilization
and partly through less effective translation. The dual-
specific protein phosphatase Dusp1 has been described
as an inhibitor of the p38MAPK-signaling module which
is able to specifically dephosphorylate MAPKs (70). By
inhibiting the activation of MAPKs such as p38s or
ERKs (for example during pro-inflammatory conditions)
Dusp1 is part of the feedback mechanism that limits in-
flammation (71). Deletion of Dusp1 results in deregula-
tion of pro- and anti-inflammatory cytokine biosynthe-
sis (15–16,18,21). The absence of Dusp1 prolongs MAPK-
activation profiles and it leads to elevated TTP protein lev-
els due to reduced dephosphorylation-dependent proteaso-
mal degradation (71). TTPbinding to theDusp1 3′UTRhas
been suggested as mechanism of Dusp1 regulation in den-
dritic cells (29). The iCLIP data presented here revealed a
direct binding of TTP and TTP-AA to the AREs within the
Dusp1 3′UTR. Analysis of Dusp1 mRNA abundance by
qPCR, protein expression and Dusp1 mRNA association
with actively translating polysomes showed dependence on
GFP–TTP and GFP–TTP-AA expression. This could con-
tribute to the prolonged MAPK-activation profile detected
in Figures 1C and 4C.
Ier3 is known to protect cells from apoptosis (55) and to
interact with the NF-B p65 subunit RelA (19,54,72). It has
previously been identified as a target of TTP (27). Ier3 has
been suggested to be regulated at the translational level in
RAW264.7 cells and cells deficient in Ier3 aremore suscepti-
ble to cell death uponLPS stimulation (14). The dependence
of Ier3 regulation on TTP was not investigated. In this re-
gard, our data indicated that TTP regulates Ier3 mRNA in
a fashion very similar to TNF mRNA and leads to strong
reduction of Ier3 protein also due to an interplay of trans-
lational control and stability regulation.
Tnfaip3/A20 was also identified as TTP target before,
but the impact of TTP-binding was only analyzed with re-
spect to destabilization of the mRNA (30). Tnfaip3/A20
is an ubiquitin-modifying enzyme and acts as a feedback
regulator in inflammation and chronic-inflammatory dis-
eases with impact on NF-B-signaling and apoptosis (73).
Here we show that its protein level can be regulated by
TTP binding to the 3′UTR of its mRNA, although mul-
tiple AREs are also detected within intronic regions of the
primary transcript. Interestingly, Tnfaip3/A20 also seems
to be post-transcriptionally regulated by Roquin (Rc3h1)
through binding to constitutive decay elements (CDEs)
within the 3′UTRof its mRNA (74). It is intriguing that two
different RBPs can bind to the same mRNAs on neighbor-
ing elements. Stringent regulatory mechanisms are needed
to orchestrate binding of the two RBPs to different recog-
nition sequences on the same transcript and simultaneous
binding can have synergistic or cross-inhibitory effects.
We observed a prolonged phosphorylation of p38MAPK
and MK2 suggesting a potential impact of GFP–TTP-
AA expression on MAPK-signaling. We presume that TTP
could act as a global negative regulator of cell signaling
upon LPS stimulation. This hypothesis was supported by
gene ontology, gene set enrichment and pathway enrich-
ment analyses that revealed ‘regulation of signal transduc-
tion’ processes and ‘cell death’ as common major func-
tions affected by TTP expression. Importantly, changes
in these processes can be linked to alterations in NF-B-
signaling that were proven at multiple levels. Altered phos-
phorylation of NF-B because of delayed activation of
its upstream activators and associated pathways resulted
in a decelerated translocation of NF-B into the nucleus.
This block of translocation was accompanied by increased
TTP-AA level detected in the nucleus (Supplementary Fig-
ure S6b, anti-GFP blots). This supports the observation
made in p38MAPK-inhibited LPS-stimulated macrophages,
where TTP also accumulated in the nucleus (75). A block
of NF-B nuclear translocation mediated by TTP was also
suggested previously (24,25). This effect can be explained
by post-transcriptional regulation of NF-B-modulators
such as Nfkbia or Nfkbiz and deregulation of feedback
inhibitors of NF-B-activation and MAPK-signaling with
known effects on the inflammatory response. However, the
phenotype of TTPaa/aa knock-in mice suggested no differ-
ences in NF-B activation, as assessed using reporter as-
says and by analyzing NF-B-dependent transcription of
TNF (26). Differences to the results presented here may
have arisen for several reasons: (i) In our study GFP–TTP-
AA is expressed to similar levels as wild-type TTP and,
therefore could have exerted more potent effects on feed-
back regulators than the very low autoregulated level of
TTP-AA in the TTPaa/aa mouse (26). Since our TTP-rescue
constructs do not contain TTP’s 3′UTR, we avoided its re-
ported autoregulation (37) leading to reduced mRNA and
protein level in mice (26). Furthermore, the N-terminal
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GFP-tag of TTP-AA could have alleviated the proteasomal
TTP-AA degradation (26,75) that occurs in an ubiquitin-
independent manner (76). Therefore, we were able to moni-
tor differences that are only due to phosphorylation and are
independent of autoregulation and altered protein stability.
(ii) In the TTPaa/aa mouse TNF was investigated as NF-B
responsive gene while our study monitored upstream post-
transcriptional events of NF-kB activation.
Deregulation of feedback inhibitors, NF-B-regulators,
cytokines and chemokines is paralleled by an increased
apoptosis of TTP-AA expressing cells before as well as dur-
ing LPS stimulation. Interestingly, the population of apop-
totic cells expresses increased amounts of TTP-AA, while
non-apoptotic cells display significantly lower TTP-AA lev-
els. This is consistent with observations made by overex-
pressing TTP in various cell lines leading to increased apop-
tosis (77). These results also corroborate the observation
that in the TTPaa/aa knock-inmousemodel the proteasome-
dependent inhibition of TTP-AAexpression is necessary for
viability of the generated animals (26). It may well be that
the TTP-AA expressing non-apoptotic cells described here
escape from apoptosis by using a similar mechanism.
Unlike Ross et al. (26), we achieved expression of TTP-
AA protein to similar levels as wild-type TTP by preventing
its autoregulation through deletion of its ARE. The levels
were also similar to endogenous amounts detected in LPS-
stimulated RAW264.7 cells. However, the basal expression
of TTP after Dox-induction before LPS stimulation does
not reflect the situation for endogenous TTP and could in-
troduce artificial LPS-independent effects on gene expres-
sion. However, our main conclusions were drawn from the
results generated after 1h of LPS stimulation and should re-
flect the physiological situation.
The modulation of TTP protein levels could have thera-
peutic potential in diseases associated with inflammation.
As shown by deleting the AREs in TTP’s mRNA the de-
structive binding of TTP to its own mRNA was avoided
and resulted in increased endogenous TTP protein level that
were beneficial in various disease models in mice (78). Tar-
geted overexpression of TTP-AA could be a new tool to al-
ter cell growth as it was shown for other phosphorylation
site mutants of TTP (79). Nonetheless, the modulation of
wild-type TTP expression or introduction of mutant TTP
protein should be considered with caution, because of the
involvement of deregulated TTP in cancer (80), its emerging
role as tumor suppressor (81) and the observed high levels of
TTP in different late-stage tumor-associated macrophages
(82). Taken together, our mechanistic transcriptome-wide
studies complement recent mouse models, functional stud-
ies at the molecular level and serve to understand the com-
plex landscape of TTP function.
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